A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants
Abroad (travel likely)RecruitingPHASE1
Conditions
Healthy Volunteers
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Quotient Sciences, Nottingham, Nottinghamshire, United Kingdom
Study leads
Bristol-Myers Squibb
Study Director
Bristol-Myers Squibb